Literature DB >> 25691191

Incidence and risk factors for retinopathy of prematurity in neonates.

Mahuya Pal Chattopadhyay1, Ashish Pradhan, Ritesh Singh, Sudip Datta.   

Abstract

We screened 50 neonates fulfilling the inclusion criteria admitted during the study period in a teaching hospital in a north-eastern state of India. Out of 50 neonates screened, 22 (44%) developed retinopathy of prematurity. There was significant association between the birth weight and gestational age of the baby at the time of the delivery with the development of ROP. Multivariate analysis of risk factors for development of ROP using a stepwise method, after controlling for various potential confounders, showed that apnea was a significant risk factor for the development of retinopathy of prematurity.

Entities:  

Mesh：

Year:  2015        PMID： 25691191     DOI： 10.1007/s13312-015-0594-1

Source DB:  PubMed          Journal:  Indian Pediatr        ISSN： 0019-6061            Impact factor:   1.411


  9 in total

Review 1.  The current state of retinopathy of prematurity in India, Kenya, Mexico, Nigeria, Philippines, Romania, Thailand, and Venezuela.

Authors:  Theodore Bowe; Lily Nyamai; Dupe Ademola-Popoola; Atchara Amphornphruet; Rachelle Anzures; Linda A Cernichiaro-Espinosa; Roseline Duke; Fahir Duran; Maria Ana Martinez-Castellanos; Prabhujot Kaur Multani; Cristina E Nitulescu; Tapas Ranjan Padhi; Boontip Tipsuriyaporn; R V Paul Chan; J Peter Campbell; Yoshihiro Yonekawa
Journal:  Digit J Ophthalmol       Date:  2019-10-12

Review 2.  Retinopathy of prematurity: a review of risk factors and their clinical significance.

Authors:  Sang Jin Kim; Alexander D Port; Ryan Swan; J Peter Campbell; R V Paul Chan; Michael F Chiang
Journal:  Surv Ophthalmol       Date:  2018-04-19       Impact factor: 6.048

3.  Appropriate dose of intravitreal ranibizumab for ROP: a retrospective study.

Authors:  Yingying Chen; Shaoli Wang; Siying Chen; Xingyue Chen; Lizhen Han; Qionglei Zhong; Kaiyan Zhang
Journal:  BMC Ophthalmol       Date:  2022-06-21       Impact factor: 2.086

4.  Correlation of interactions between NOS3 polymorphisms and oxygen therapy with retinopathy of prematurity susceptibility.

Authors:  Chunhong Yu; Jinglin Yi; Xiaolong Yin; Yan Deng; Yujun Liao; Xiaobing Li
Journal:  Int J Clin Exp Pathol       Date:  2015-11-01

5.  Abnormal Complement Activation and Inflammation in the Pathogenesis of Retinopathy of Prematurity.

Authors:  Sonika Rathi; Subhadra Jalali; Satish Patnaik; Shahna Shahulhameed; Ganeswara R Musada; Divya Balakrishnan; Padmaja K Rani; Ramesh Kekunnaya; Preeti Patil Chhablani; Sarpras Swain; Lopamudra Giri; Subhabrata Chakrabarti; Inderjeet Kaur
Journal:  Front Immunol       Date:  2017-12-22       Impact factor: 7.561

6.  Influence of Anaemia on Multifactorial Disease Retinopathy of Prematurity: A Prospective Observational Study.

Authors:  Manish Tandon; Raksha Ranjan; Uma Muralidharan; A Kannan
Journal:  Cureus       Date:  2022-08-11

7.  Evaluation of an innovative low flow oxygen blender system for global access.

Authors:  Ellie Ng; Michelle Dundek; Thomas F Burke
Journal:  Front Pediatr       Date:  2022-09-12       Impact factor: 3.569

Review 8.  Prevalence and Risk Factors of Retinopathy of Prematurity in Iran.

Authors:  Mohammad Zarei; Fatemeh Bazvand; Nazanin Ebrahimiadib; Ramak Roohipoor; Reza Karkhaneh; Afsar Farahani Dastjani; Marjan Imani Fouladi; Mohammad Riazi Esfahani; Alireza Khodabande; Samaneh Davoudi; Hamed Ghasemi; Bobeck S Modjtahedi
Journal:  J Ophthalmic Vis Res       Date:  2019-07-18

9.  Availability and use of continuous positive airway pressure (CPAP) for neonatal care in public health facilities in India: a cross-sectional cluster survey.

Authors:  Juan Emmanuel Dewez; Sushma Nangia; Harish Chellani; Sarah White; Matthews Mathai; Nynke van den Broek
Journal:  BMJ Open       Date:  2020-02-28       Impact factor: 2.692
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.